{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:09:12Z","timestamp":1790460552011,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bulcan.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T20:26:44Z","timestamp":1464467204000},"page":"651-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Consortium de d\u00e9tection et prise en charge des atteintes pulmonaires induites par la bl\u00e9omycine"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-1197","authenticated-orcid":false,"given":"Josette","family":"Biya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Stoclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Le Pavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Ferm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-2516","authenticated-orcid":false,"given":"Maxime","family":"Annereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ekpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-3331","authenticated-orcid":false,"given":"Jean-Marie","family":"Michot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bulcan.2016.04.005_bib0250","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.120.2.617","article-title":"Bleomycin-induced pneumonitis","volume":"120","author":"Sleijfer","year":"2001","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.bulcan.2016.04.005_bib0255","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/bjc.1998.628","article-title":"Fatal bleomycin pulmonary toxicity in the west of Scotland 1991\u201395: a review of patients with germ cell tumours","volume":"78","author":"Simpson","year":"1998","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdg020","article-title":"Predicting the risk of bleomycin lung toxicity in patients with germ cell tumours","volume":"14","author":"O'Sullivan","year":"2003","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00277-010-1032-z","article-title":"Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma","volume":"90","author":"Ngeow","year":"2011","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.bulcan.2016.04.005_bib0270","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.86.5.723","article-title":"Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids","volume":"86","author":"White","year":"1984","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.bulcan.2016.04.005_bib0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.bulcan.2016.04.005_bib0280","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Suppl. 5","key":"10.1016\/j.bulcan.2016.04.005_bib0285","first-page":"3","article-title":"Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokinetics","volume":"19","author":"Dorr","year":"1992","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2016.04.005_bib0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00253118","article-title":"Bleomycin pharmacokinetics in man. I. Intravenous administration","volume":"1","author":"Alberts","year":"1978","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"10.1016\/j.bulcan.2016.04.005_bib0295","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1200\/JCO.2007.14.1606","article-title":"Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer","volume":"26","author":"de Haas","year":"2008","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.bulcan.2016.04.005_bib0300","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1021\/bi00442a003","article-title":"Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family","volume":"28","author":"Sebti","year":"1989","journal-title":"Biochemistry (Mosc)"},{"issue":"4","key":"10.1016\/j.bulcan.2016.04.005_bib0305","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N","article-title":"A clinical review of bleomycin\u00a0\u2013\u00a0a new antineoplastic agent","volume":"31","author":"Blum","year":"1973","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2016.04.005_bib0310","first-page":"185","article-title":"The pathogenesis of bleomycin-induced pulmonary fibrosis in mice","volume":"77","author":"Adamson","year":"1974","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1165\/ajrcmb.16.1.8998084","article-title":"Apoptosis and expression of Fas\/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice","volume":"16","author":"Hagimoto","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.bulcan.2016.04.005_bib0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02034932","article-title":"Mechanisms of bleomycin-induced lung damage","volume":"65","author":"Hay","year":"1991","journal-title":"Arch Toxicol"},{"issue":"30","key":"10.1016\/j.bulcan.2016.04.005_bib0330","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1200\/JCO.2005.02.7243","article-title":"Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2016.04.005_bib0335","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00000441-198803000-00006","article-title":"Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide","volume":"295","author":"Lower","year":"1988","journal-title":"Am J Med Sci"},{"issue":"13","key":"10.1016\/j.bulcan.2016.04.005_bib0340","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.bulcan.2016.04.005_bib0345","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.1504780112","article-title":"Telomere dysfunction causes alveolar stem cell failure","volume":"112","author":"Alder","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8920","key":"10.1016\/j.bulcan.2016.04.005_bib0350","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(94)91805-8","article-title":"Pulmonary toxicity of bleomycin: is G-CSF a risk factor?","volume":"344","author":"Bastion","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bulcan.2016.04.005_bib0355","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.111.3.657","article-title":"Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte-colony stimulating factor","volume":"111","author":"Saxman","year":"1997","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.bulcan.2016.04.005_bib0360","first-page":"1074","article-title":"Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphologic assessment","volume":"126","author":"Tryka","year":"1982","journal-title":"Am Rev Respir Dis"},{"issue":"6128","key":"10.1016\/j.bulcan.2016.04.005_bib0365","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/bmj.1.6128.1664","article-title":"Factors influencing postoperative morbidity and mortality in patients treated with bleomycin","volume":"1","author":"Goldiner","year":"1978","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.bulcan.2016.04.005_bib0370","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0022-5347(01)62533-3","article-title":"Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?","volume":"160","author":"Donat","year":"1998","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.bulcan.2016.04.005_bib0375","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01213011-200506000-00005","article-title":"Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients","volume":"15","author":"Nuver","year":"2005","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0380","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1995.24","article-title":"Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect","volume":"71","author":"Sleijfer","year":"1995","journal-title":"Br J Cancer"},{"issue":"695","key":"10.1016\/j.bulcan.2016.04.005_bib0385","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1259\/0007-1285-58-695-1041","article-title":"Bleomycin lung: computed tomographic observations","volume":"58","author":"Rimmer","year":"1985","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.bulcan.2016.04.005_bib0390","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1164-6756(01)00119-0","article-title":"Pneumopathies aigu\u00ebs infectieuses chez l\u2019immunod\u00e9prim\u00e9 en dehors du sida","volume":"10","author":"Gainnier","year":"2001","journal-title":"Reanimation"},{"issue":"4","key":"10.1016\/j.bulcan.2016.04.005_bib0395","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.bulcan.2016.04.005_bib0400","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/thx.42.7.551","article-title":"Bronchoalveolar lavage cell populations in bleomycin lung toxicity","volume":"42","author":"White","year":"1987","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0405","first-page":"48","article-title":"Natural course of bleomycin-induced pneumonitis. A follow-up study","volume":"135","author":"Van Barneveld","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"8","key":"10.1016\/j.bulcan.2016.04.005_bib0410","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1440-1827.1995.tb03503.x","article-title":"Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats","volume":"45","author":"Usuki","year":"1995","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0415","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-88-1-47","article-title":"Bleomycin hypersensitivity pneumonitis","volume":"88","author":"Holoye","year":"1978","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1378\/chest.88.1.103","article-title":"Chemotherapy-induced eosinophilic pneumonia. Relation to bleomycin","volume":"88","author":"Yousem","year":"1985","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.bulcan.2016.04.005_bib0425","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(19890815)64:4<806::AID-CNCR2820640407>3.0.CO;2-X","article-title":"Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma","volume":"64","author":"Santrach","year":"1989","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2016.04.005_bib0430","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thorax.55.4.318","article-title":"Organising pneumonia","volume":"55","author":"Cordier","year":"2000","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0435","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2016.04.005_bib0440","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"issue":"1","key":"10.1016\/j.bulcan.2016.04.005_bib0445","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1164\/ajrccm.155.1.9001318","article-title":"Adjustment of DLCO for hemoglobin concentration","volume":"155","author":"Marrades","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.bulcan.2016.04.005_bib0450","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S1470-2045(14)70490-5","article-title":"Personalised chemotherapy based on tumour marker decline in poor prognosis germ cell tumours (GETUG 13): a phase 3, multicentre, randomised trial","volume":"15","author":"Fizazi","year":"2014","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2016.04.005_bib0455","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/annonc\/mdq021","article-title":"Poor prognosis nonseminomatous germ cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?","volume":"21","author":"Massard","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2016.04.005_bib0460","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2016.04.005_bib0465","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1200\/JCO.1990.8.5.765","article-title":"Detecting bleomycin pulmonary toxicity: a continued conundrum","volume":"8","author":"Comis","year":"1990","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2016.04.005_bib0470","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","article-title":"Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial","volume":"182","author":"Azoulay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.bulcan.2016.04.005_bib0475","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1398-9995.2005.00812.x","article-title":"Eosinophilic pneumonias","volume":"60","author":"Cottin","year":"2005","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.bulcan.2016.04.005_bib0480","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.bulcan.2016.04.005_bib0485","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/09031936.00152106","article-title":"Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis","volume":"29","author":"Chaudhary","year":"2007","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.bulcan.2016.04.005_bib0245","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J Clin Invest"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116300625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116300625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T11:59:43Z","timestamp":1536667183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455116300625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0007455116300625"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.04.005","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consortium de d\u00e9tection et prise en charge des atteintes pulmonaires induites par la bl\u00e9omycine","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}